183 related articles for article (PubMed ID: 32369181)
21. Metformin Reduces NGF-Induced Tumour Promoter Effects in Epithelial Ovarian Cancer Cells.
Garrido MP; Salvatierra R; Valenzuela-Valderrama M; Vallejos C; Bruneau N; Hernández A; Vega M; Selman A; Quest AFG; Romero C
Pharmaceuticals (Basel); 2020 Oct; 13(10):. PubMed ID: 33081077
[TBL] [Abstract][Full Text] [Related]
22. Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma.
Davidson B; Reich R; Lazarovici P; Nesland JM; Skrede M; Risberg B; Tropé CG; Flørenes VA
Clin Cancer Res; 2003 Jun; 9(6):2248-59. PubMed ID: 12796393
[TBL] [Abstract][Full Text] [Related]
23. Follicle stimulating hormone receptor in ovarian surface epithelium and epithelial ovarian cancer.
Bose CK
Oncol Res; 2008; 17(5):231-8. PubMed ID: 18980020
[TBL] [Abstract][Full Text] [Related]
24. The interactions between nerve growth factor and gonadotrophins in bovine oviduct.
Li C; Ma Y; Yi K; Wang C; Li W; Liu Z; Sun L; Chen S; Yu J; Li H; Chen L; Zhou X
Anim Reprod Sci; 2014 Oct; 149(3-4):117-23. PubMed ID: 25042774
[TBL] [Abstract][Full Text] [Related]
25. VEGF expression and enhanced production by gonadotropins in ovarian epithelial tumors.
Wang J; Luo F; Lu JJ; Chen PK; Liu P; Zheng W
Int J Cancer; 2002 Jan; 97(2):163-7. PubMed ID: 11774259
[TBL] [Abstract][Full Text] [Related]
26. Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone.
Zheng W; Lu JJ; Luo F; Zheng Y; Feng Yj; Felix JC; Lauchlan SC; Pike MC
Gynecol Oncol; 2000 Jan; 76(1):80-8. PubMed ID: 10620446
[TBL] [Abstract][Full Text] [Related]
27. Role of Mitochondria in Interplay between NGF/TRKA, miR-145 and Possible Therapeutic Strategies for Epithelial Ovarian Cancer.
Vera DB; Fredes AN; Garrido MP; Romero C
Life (Basel); 2021 Dec; 12(1):. PubMed ID: 35054401
[TBL] [Abstract][Full Text] [Related]
28. [Preliminary study on pathway of follicle-stimulating hormone on human epithelial ovarian cancer cell proliferation].
Sheng L; Liu DY; Shen K
Zhonghua Fu Chan Ke Za Zhi; 2003 Dec; 38(12):752-5. PubMed ID: 14728848
[TBL] [Abstract][Full Text] [Related]
29. Reactive oxygen species regulate FSH-induced expression of vascular endothelial growth factor via Nrf2 and HIF1α signaling in human epithelial ovarian cancer.
Zhang Z; Wang Q; Ma J; Yi X; Zhu Y; Xi X; Feng Y; Jin Z
Oncol Rep; 2013 Apr; 29(4):1429-34. PubMed ID: 23404377
[TBL] [Abstract][Full Text] [Related]
30. Role of nerve growth factor and its TRKA receptor in normal ovarian and epithelial ovarian cancer angiogenesis.
Vera C; Tapia V; Vega M; Romero C
J Ovarian Res; 2014 Aug; 7():82. PubMed ID: 25296882
[TBL] [Abstract][Full Text] [Related]
31. Potential role of follicle-stimulating hormone (FSH) and transforming growth factor (TGFβ1) in the regulation of ovarian angiogenesis.
Kuo SW; Ke FC; Chang GD; Lee MT; Hwang JJ
J Cell Physiol; 2011 Jun; 226(6):1608-19. PubMed ID: 20945379
[TBL] [Abstract][Full Text] [Related]
32. Role of nerve growth factor and FSH receptor in epithelial ovarian cancer.
Bose CK
Reprod Biomed Online; 2005 Aug; 11(2):194-7. PubMed ID: 16168216
[TBL] [Abstract][Full Text] [Related]
33. NGF-Enhanced Vasculogenic Properties of Epithelial Ovarian Cancer Cells Is Reduced by Inhibition of the COX-2/PGE
Garrido MP; Hurtado I; Valenzuela-Valderrama M; Salvatierra R; Hernández A; Vega M; Selman A; Quest AFG; Romero C
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31817839
[TBL] [Abstract][Full Text] [Related]
34. Autocrine VEGF-A/KDR loop protects epithelial ovarian carcinoma cells from anoikis.
Sher I; Adham SA; Petrik J; Coomber BL
Int J Cancer; 2009 Feb; 124(3):553-61. PubMed ID: 19004006
[TBL] [Abstract][Full Text] [Related]
35. [Expression and clinical significance of endostatin and vascular endothelial growth factor in ovarian carcinoma].
Shi HR; Song WJ; Chen ZM; Wu QH
Ai Zheng; 2005 Sep; 24(9):1127-31. PubMed ID: 16159439
[TBL] [Abstract][Full Text] [Related]
36. Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer.
Sopo M; Anttila M; Hämäläinen K; Kivelä A; Ylä-Herttuala S; Kosma VM; Keski-Nisula L; Sallinen H
BMC Cancer; 2019 Jun; 19(1):584. PubMed ID: 31200683
[TBL] [Abstract][Full Text] [Related]
37. The Role of Angiogenesis in the Persistence of Chemoresistance in Epithelial Ovarian Cancer.
Nusrat O; Belotte J; Fletcher NM; Memaj I; Saed MG; Diamond MP; Saed GM
Reprod Sci; 2016 Nov; 23(11):1484-1492. PubMed ID: 27122375
[TBL] [Abstract][Full Text] [Related]
38. Effects of antisense oligodeoxynucleotide to follicle-stimulating hormone receptor on the expression of proliferating cell nuclear antigen and vascular endothelial growth factor in primary culture cells derived from human ovarian mucinous cystadenocarcinoma.
Li S; Liu H; Wang L; Zhu C
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(1):111-5. PubMed ID: 16711022
[TBL] [Abstract][Full Text] [Related]
39. Follicle-stimulating hormone promotes the growth of human epithelial ovarian cancer cells through the protein kinase C-mediated system.
Ohtani K; Sakamoto H; Kikuchi A; Nakayama Y; Idei T; Igarashi N; Matukawa T; Satoh K
Cancer Lett; 2001 May; 166(2):207-13. PubMed ID: 11311494
[TBL] [Abstract][Full Text] [Related]
40. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems.
Wang J; Lin L; Parkash V; Schwartz PE; Lauchlan SC; Zheng W
Int J Cancer; 2003 Jan; 103(3):328-34. PubMed ID: 12471615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
